Site activation most often stalls at the clinical trial agreement and the site budget. Not because anyone is careless, but because the negotiation involves several parties with different incentives and timelines, and because sponsors often arrive with templates and budgets that do not reflect how sites actually work.
Why do site contracts and budgets take so long?
Many reviewers. Legal, finance, research administration and, at academic centers, coverage analysis all weigh in.
Template friction. Sponsor terms on subject injury, indemnification, publication and confidentiality are routinely redlined, and the same debates repeat site after site.
Budget gaps. Disagreements over fair market value, startup fees, pharmacy and IRB fees, screen failure reimbursement and overhead.
Sequential work. The budget waits for the contract, or the contract waits for the budget, while IRB review waits for both.
Limited authority. When a CRO negotiates on the sponsor's behalf without authority to accept common changes, every redline travels back to the sponsor and waits.
What can sponsors control?
More than they think.
Pre-approved fallback language. Give your CRO authority to accept common redlines within defined bounds, so routine changes don't need sponsor approval.
Realistic budgets. Build from site-level cost drivers, include invoiceable items and pay reasonable startup costs up front.
Parallel processing. Run contract, budget, ethics review and site readiness at the same time.
Fast decisions. Commit to turning sponsor approvals around in days, not weeks.
Master agreements. Use them with sites and networks you expect to work with again.
How should the CRO's role be set up?
Be explicit in the contract and in governance: who negotiates, with what authority, how quickly escalations are answered and which metrics are tracked. Ask for weekly status by site with blockers named, not a single percentage of sites activated.
Why does it matter so much?
Every week a high-enrolling site waits is a week of enrollment you will not get back. There is a relationship cost too. A site that feels squeezed on budget or ignored on redlines will quietly prioritize other sponsors' studies, long after the contract is signed.
It also helps to know which sites are likely to be slow before you choose them. Ask feasibility questions about typical contract and budget cycle times, whether the institution uses a master agreement and who signs. A site with an excellent investigator and a long contracting process may still be worth including, but plan for that reality rather than discovering it.
Which metrics show where the delays are?
Track cycle time from contract sent to fully executed, the number of negotiation rounds and the most frequent redline categories. Use that data to revise your templates and budget assumptions before the next study. Most sponsors negotiate the same clauses again and again without ever changing the starting point.
Want help structuring your CRO's startup responsibilities? Learn about ABRA's CRO Selection & Management support.
